November 2019 Bonus ASH Annual Meeting Preview Edition
Volume 5, Issue 14
This issue offers an inside look at this year’s annual meeting, advice for giving effective presentations, and more.
Table of Contents
November 2019 Bonus Issue
How To Give a Talk
In this special edition of “How We Teach,” Mikkael Sekeres, MD, MS, and Joseph Mikhael, MD, MEd, offer advice to new – and experienced –...
November 2019 Bonus Issue
FDA Issues Guidelines for Regulating Health Artificial Intelligence
The FDA provided new guidance on the regulation of mobile health software and clinical decision support (CDS) tools that use artificial intelligence (AI). The...
Democrats and Republicans Unveil Competing Drug Pricing Bills
Lowering drug costs is a major bipartisan voter issue, but tensions between parties have been escalating as Democrats introduced a bill that would allow...
FDA Approves Daratumumab-Based Quadruplet Regimen for Transplant-Eligible Myeloma
The U.S. Food and Drug Administration (FDA) approved the quadruplet regimen consisting of daratumumab, bortezomib, thalidomide, and dexamethasone to treat adult patients with newly...
NSTC Developing New Plans to Reduce Foreign Influence on U.S. Research
Co-chair of the National Science and Technology Council (NSTC) Kelvin Droegemeier, PhD, is developing new requirements for what information researchers must disclose to receive...
November 2019 Bonus Issue
Coagulation Conundrums: Managing Hemostatic and Thrombotic Complications in Young Women
In a case-based discussion as part of this year’s Education Program, Andra James, MD, MPH, and Margaret Ragni, MD, MPH, will answer challenging questions...
ASH-a-Palooza Redux
The 2018 ASH Annual Meeting in San Diego marked the debut of ASH-a-Palooza, the reimagined Trainee Day. This new educational experience offers a relaxed,...
DOACs: From Clinical Trials to Real-World Clinical Encounters
In the last decade, five direct oral anticoagulants (DOACs) have made their way to the clinic, but clinicians may encounter challenging patient scenarios for...
200 Years of Hodgkin Lymphoma
This year’s ASH Education Program features a look at the progress that has been made in the two centuries since Thomas Hodgkin entered medicine....
Education Program Preview
Interview with Education Program Co-Chairs Elisabeth Battinelli, MD, PhD, and Jason Gotlib, MD, MS
What are your goals for this year’s education program?
Dr. Gotlib: We...
Scientific Program Preview
Interview with Scientific Program Co-Chairs Robert Flaumenhaft, MD, PhD, and Charles Mullighan, MBBS (Hons), MD
What are your goals for this year’s scientific program?
Dr. Flaumenhaft:...
A Global Perspective on Chronic Myeloid Leukemia
In the U.S. and other high-income countries, access to testing and first-, second-, and third-generation tyrosine kinase inhibitors has improved the management and prognosis...
Drug Problems: Hematologic Complications of Illicit Drug Use
In an Education Spotlight Session at this year’s ASH Annual Meeting, experts will be looking at the potentially devastating hematologic complications of illicit drug...
